A study of right turn on red at signalized intersections

Traffic engineers have discussed the controversial subject of allowing drivers to make a right-turn-on-red (R.T.O.R.) for many years. There have been many strong points given for and against allowing this movement. Within this paper R.T.O.R. is discussed and conclusions are drawn for a research of literature and questionnaire survey. Questionnaires were sent to ninety-three cities and all fifty states. Many valuable unwritten facts and opinions were received from the seventy city and thirty-six state traffic engineers that completed and returned the questionnaires. It was determined that 63.8% of the states replying and 64.3% of the cities are presently utilizing R.T.O.R. Since 1967, R.T.O.R. has been implemented by 47.8% of the states and 31.1% of the cities who indicated they are presently using it. Traffic engineers seem to agree that nonuniformity in signing, warrants, and regulations are the main problems which hinder the effectiveness and acceptance of R.T.O.R. R.T.O.R. is a valuable traffic tool that is rapidly being accepted by drivers, pedestrians, and traffic engineers. Like many other popular good things it will also become better with age. --Abstract, page ii

The Aerogen® Solo Is an Alternative to the Small Particle Aerosol Generator (SPAG-2) for Administration of Inhaled Ribavirin

Respiratory syncytial virus (RSV) is associated with adverse outcomes among immunocompromised patients. Inhaled ribavirin has been shown to improve mortality rates. The Small-Particle Aerosol Generator delivery system (SPAG-2) is the only FDA-cleared device to deliver inhaled ribavirin. However, it is difficult to set up and maintain. We developed a method for delivery of this medication using the vibrating mesh nebulizer (Aerogen®). We did not observe any adverse events with this method